OClawVPS.com
Viking Global
Edit

Viking Global

https://vikingglobal.com/
Last activity: 19.01.2026
Active
Inspired by opportunities. Guided by intellectual honesty.
Portfolio
10
Persons
6
Mentions
101

Portfolio 10

DateNameWebsiteTotal RaisedLocation
17.12.2025Medlinemedline.com$6.26BUnited Sta...
20.10.2025Veradermic...veradermics.com$225MUnited Sta...
23.09.2025Ensomaensoma.com$258MUnited Sta...
12.07.2023Allonniaallonnia.com$90MUnited Sta...
07.06.2023Ecovativeecovative.com$69M-
08.05.2023Solarea Bi...solareabio.com$26.2MUnited Sta...
25.03.2023Pragma Biopragmabio.com$10MUnited Sta...
19.01.2023SetPoint M...setpointmedical.com$327MUnited Sta...
05.01.2023Mantra Biomantrabio.com$34MUnited Sta...
02.09.2021Biome Make...biomemakers.com$21.2MUnited Sta...

Persons 6

DateFirst NameLast NameTitleLinkedInLocation
-SamuelCarmoInformatio...linkedin.c...-
-KarinSmithHuman Reso...linkedin.c...-
-AronNataleHead of Pe...linkedin.c...-
-AlexGeorgeInformatio...linkedin.c...-
-RohanNirodyInvestment...linkedin.c...-
-DavidVaccaroTraderlinkedin.c...-

Mentions in press and media 101

DateTitleDescription
19.01.2026Here’s how much money the world’s biggest hedge funds made in a record-breaking 2025-
11.01.2026Diagonal Therapeutics Secures $125M to Propel Innovative Antibody TherapiesDiagonal Therapeutics secured $125M Series B funding. This advances DIAG723, a first-in-class clustering antibody. It targets hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH). The Watertown biotech corre...
11.01.2026Diagonal Therapeutics: $125 Million Series B Raised To Advance DIAG723 Clustering Antibody Into the ClinicDiagonal Therapeutics announced it has raised $125 million in an oversubscribed Series B financing to advance its lead program, DIAG723, a first-in-class “clustering antibody” designed to correct dysregulated receptor signaling implicated i...
09.01.2026Diagonal Therapeutics Raises $125M in Series B FinancingDiagonal Therapeutics, a Watertown, MA-based biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases, raised $125M in Series B Funding. The round was co-led by ...
19.12.2025Medline's Monumental IPO: A Beacon Amidst Market TurbulenceMedline's colossal $6.26 billion initial public offering seized market attention. The medical supply giant's debut stands as the largest U.S. offering since 2021. Its shares experienced a significant post-listing surge. This strong performa...
17.12.2025Американский производитель медтоваров Medline привлек $6,26 млрд в крупнейшем IPO годаАкции Medline Inc. выросли на 21% в день начала торгов после того, как поставщик медицинской продукции привлек $6,26 млрд в крупнейшем первичном публичном размещении акций в этом году. Торги начались по цене $35 за акцию против цены размеще...
16.12.2025Allonnia Secures $20M+ to Revolutionize Mineral ExtractionAllonnia, a Boston-based biotech firm, just closed a $20 million+ Series A extension. This brings total funding past $100 million. The company aims to improve mineral recovery and lessen environmental damage. Demand for critical minerals is...
12.12.2025Allonnia: Over $20 Million In Series A Extension Closed To Advance Critical Materials BiotechnologyAllonnia, a Boston-based bio-ingenuity company focused on improving mineral recovery while reducing environmental impact, has raised more than $20 million in a Series A extension round. The financing was led by Viking Global Investors, Biso...
10.12.2025Allonnia Raises More Than $20M in Series A Extension FundingAllonnia, a Boston, MA-based bio-ingenuity company that develops scalable solutions to improve mineral recovery and reduce environmental impact, raised more than $20M in Series A extension funding. The round was led by Viking Global Investo...
20.10.2025Veradermics: $150 Million Series C Raised For Advancing Late-Stage Trials Of VDPHL01Veradermics, a dermatologist-founded, late clinical-stage biopharmaceutical company developing first-in-class treatments for common dermatologic conditions, has announced the completion of an oversubscribed $150 million Series C financing r...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In